Apollomics, Inc.
APLM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -75.9% | 154.2% | 16,050% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20,734.8% | -6,509.9% | -13,586.1% | -2,505,850% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27,201% | -21,023.3% | -74,554.5% | -4,739,850% |
| EPS Diluted | -52.8 | -231.99 | -61.6 | -23.45 |
| % Growth | 77.2% | -276.6% | -162.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |